Incidence and predictors for cardiovascular events in patients with psoriatic arthritis

被引:85
|
作者
Eder, Lihi [1 ]
Wu, Ying [2 ]
Chandran, Vinod [1 ]
Cook, Richard [2 ]
Gladman, Dafna D. [1 ]
机构
[1] Toronto Western Hosp, Ctr Prognosis Studies Rheumat Dis, Toronto, ON, Canada
[2] Univ Waterloo, Dept Stat & Actuarial Sci, Waterloo, ON, Canada
基金
加拿大健康研究院;
关键词
Psoriatic Arthritis; Epidemiology; Atherosclerosis; Cardiovascular Disease; ATHEROSCLEROSIS RISK-FACTORS; POPULATION-BASED COHORT; RHEUMATOID-ARTHRITIS; SUBCLINICAL ATHEROSCLEROSIS; FRAMINGHAM RISK; DISEASE; INFLAMMATION; METAANALYSIS; PREVALENCE; INDIVIDUALS;
D O I
10.1136/annrheumdis-2015-207980
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To assess the incidence and risk factors of cardiovascular events in patients with psoriatic arthritis (PsA). Methods A cohort analysis was conducted involving patients recruited and followed over the period from 1978 to 2013 in a large PsA clinic. The participants were assessed at 6 to 12-month intervals according to a standard protocol. The collected information included demographics, lifestyle habits, medical history, medications use and PsA-related outcomes. The primary outcome was a composite major cardiovascular end point comprising myocardial infarction, ischaemic stroke, revascularisation or cardiovascular death. The association between the features of disease activity and the occurrence of cardiovascular events was assessed using Cox proportional hazard models. Results A total of 1091 patients with PsA were analysed. During the follow-up period, 104 cardiovascular events occurred. A considerable proportion of patients developed a cardiovascular event (19.8% of the patients by the age of 70 years and 30.1% of patient by the age of 80 years). No trend in the risk of developing cardiovascular events was observed over the decades from 1978 to 2013 (p=0.73). In multivariate analysis, the following variables were independent predictors of major cardiovascular events: hypertension (relative risk (RR) 1.81, p=0.015), diabetes (RR 2.72, p<0.001) and the number of dactylitic digits (RR 1.20, p<0.001). Sedimentation rate was a significant predictor only among women (RR 1.83, p=0.02). Conclusion A significant proportion of patients with PsA develop cardiovascular events during the course of their disease. Increased cardiovascular risk is associated with a combination of traditional cardiovascular risk factors and disease activity.
引用
收藏
页码:1680 / 1686
页数:7
相关论文
共 50 条
  • [21] PREDICTING CARDIOVASCULAR EVENTS IN PATIENTS WITH SPONDYLOARTHRITIS AND PSORIATIC ARTHRITIS: THREE RISK ALGORITHMS
    Pinto, A. S.
    Cunha Santos, F.
    Dinis, S. P.
    Ferreira, J. F.
    Vaz, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1900 - 1900
  • [22] Prevention and risk assessment of cardiovascular events in a population of patients with psoriasis and psoriatic arthritis
    Olszewski, Robert
    Cwiklinska, Klaudia
    Maslinska, Maria
    Kwiatkowska, Brygida
    REUMATOLOGIA, 2022, 60 (04): : 266 - 274
  • [23] INCIDENCE AND PREVALENCE OF CARDIOVASCULAR RISK FACTORS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS, PSORIASIS, OR PSORIATIC ARTHRITIS
    Solomon, D. H.
    Lesperance, T.
    Radner, H.
    Accortt, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 411 - 411
  • [24] CARDIAC BIOMARKERS ARE ASSOCIATED WITH THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS
    Colaco, K.
    Lee, K. A.
    Akhtari, S.
    Winer, R.
    Welsh, P.
    Sattar, N.
    Mcinnes, I.
    Chandran, V.
    Harvey, P.
    Cook, R.
    Gladman, D. D.
    Piguet, V.
    Eder, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 812 - 813
  • [25] Cardiac Biomarkers Are Associated with the Development of Cardiovascular Events in Patients with Psoriatic Arthritis and Psoriasis
    Colaco, Keith
    Lee, Ker-Ai
    Akhtari, Shadi
    Winer, Raz
    Welsh, Paul
    Sattar, Naveed
    McInnes, Iain
    Chandran, Vinod
    Harvey, Paula
    Cook, Richard
    Gladman, Dafna
    Piguet, Vincent
    Eder, Lihi
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [26] Cardiac Biomarkers are Associated With the Development of Cardiovascular Events in Patients With Psoriatic Arthritis and Psoriasis
    Colaco, Keith
    Lee, Ker-Ai
    Akhtari, Shadi
    Winer, Raz
    Welsh, Paul
    Sattar, Naveed
    McInnes, Iain
    Chandran, Vinod
    Harvey, Paula
    Cook, Richard
    Piguet, Vincent
    Gladman, Dafna
    Eder, Lihi
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (07) : 1141 - 1141
  • [27] ASSOCIATION BETWEEN BASELINE CARDIOVASCULAR RISK AND INCIDENCE RATES OF MAJOR ADVERSE CARDIOVASCULAR EVENTS AND MALIGNANCIES IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS RECEIVING TOFACITINIB
    Kristensen, L. E.
    Strober, B.
    Poddubnyy, D.
    Leung, Y. Y.
    Jo, H.
    Kwok, K.
    Vranic, I.
    Fleishaker, D.
    Fallon, L.
    Yndestad, A.
    Gladman, D. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 20 - 20
  • [28] Association between baseline cardiovascular risk and incidence rates of major adverse cardiovascular events and malignancies in patients with psoriatic arthritis and psoriasis receiving tofacitinib
    Kristensen, Lars E.
    Strober, Bruce
    Poddubnyy, Denis
    Leung, Ying-Ying
    Jo, Hyejin
    Kwok, Kenneth
    Vranic, Ivana
    Fleishaker, Dona L.
    Fallon, Lara
    Yndestad, Arne
    Gladman, Dafna D.
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2023, 15
  • [29] Cardiovascular risk in patients with psoriatic arthritis
    Korotaeva, T. V.
    Novikova, D. S.
    Loginova, E. Yu.
    TERAPEVTICHESKII ARKHIV, 2016, 88 (05) : 102 - 106